Raymond James Financial Services Advisors »

Black Diamond Therapeutics shares owned by Raymond James Financial Services Advisors

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Raymond James Financial Services Advisors from 13F filings

Historical chart of Raymond James Financial Services Advisors investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Raymond James Financial Services Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Raymond James Financial Services Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $87k 17k 5.07

More positions owned by Raymond James Financial Services Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Vanguard Index Fds Value Etf (VTV)
Home Depot (HD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Raymond James Financial Services Advisors

Top funds holding Black Diamond Therapeutics

Bellevue Group
NEA Management Company
RA Capital Management
Vanguard Group
Tang Capital Management
BlackRock
Artal Group
Kennedy Capital Management
Blue Owl Capital Holdings
Ikarian Capital
Boxer Capital
Susquehanna International
Geode Capital Management
Two Sigma Investments
Verition Fund Management

View all funds holding Black Diamond Therapeutics